IDH1 mutant status may be one of the decisive factors behind such relationship, because IDH1 mutation is frequently observed in diffuse gliomas but rarely seen in primary glioblastomas (WHO grade IV) (20). This evidence concerns the gene IDH1 and glioblastoma.